Prof. Atta-ur-Rahman, Ph.D. in organic chemistry from Kings College, University of Cambridge (1968), has 1235 international publications in several fields of organic chemistry including, 349 books published largely by major U.S. and European presses. He was elected as Fellow of Royal Society (London) (2006) and won the prestigious UNESCO Science Prize (1999).Prof. Atta-ur-Rahman was conferred honorary D.Sc. degrees by many leading world universities including the University of Cambridge and appointed an Honorary Life Fellow of Kings College, University of Cambridge. The Austrian government honoured him with its high civil award (“Grosse Goldene Ehrenzeischen am Bande") (2007). He is Professor Emeritus at the University of Karachi, Pakistan. Prof. Atta-ur-Rahman was appointed Academician (Foreign Member) of the Chinese Academy of Sciences (2015). He won the “Friendship Award of China” (2014) and was conferred the highest scientific award of China, the International Science & Technology Cooperation Award, by President Xi Jinping (2020). He was bestowed with the International Scientific Corporation Award (2014) and the “Einstein Professorship” by the Chinese Academy of Sciences (CAS) (2013). He was also elected as Foreign Member of the Korean Academy of Science and Technology. Research Institutes have been established in his name in China, Malaysia and Pakistan.

I am a professor from College of Life Sciences, Wuhan University, China. I has more than 20 years of experience in the research of animal toxin peptides, involving in cDNA, genome, biological and pharmacological roles (such as anti-virus, anti-tumor, ion-channel-modulating), molecular diversity and evolution. I graduated Ph.D from College of Life Sciences, Wuhan University, China in 2004. I was also a visiting scholar of Meharry Medical College, USA from 2014 to 2015. Notably, I has authored more than 100 manuscripts and 12 patents. I was an Excellent Young Scholar of China National Science Fund in 2014 and got Youth Science and Technology Award from Chinese Society of Toxicology in 2016.

Dr. Shunbin Ning is an associate professor in the Department of Internal Medicine, East Tennessee State University, USA. He is interested in the interaction between chronic viral infections and the host innate immune system in carcinogenesis, with focus on type I IFN-mediated innate immune system, DNA damage response, autophagy, and oxidative stress. The long-term goal of these studies is to identify molecular targets for cancer immunotherapeutic and antiviral therapeutic applications.

Hassan Y. Aboul Enein is a Professor and Pharmaceutical Consultant at the Pharmaceutical and Medicinal Chemistry Department, National Research Center in Cairo, Egypt. Professor Aboul-Enein is the author and coauthor of over 1200 refereed articles, 62 book chapters and 380 conference presentations (h-index 51-Scopus). He is also authored and edited 10 books in the field of analytical chemistry and pharmaceutical chemistry. He is an Editorial Board Member of some 22 journals. He is a Member of the World Health Organization (WHO) advisory panel in International Pharmacopoeia and Pharmaceutical Preparations and a Fellow of the Royal Society of Chemistry (UK).

Dr. Gaurav Dhiman received his Ph.D. in Computer Engineering from Thapar Institute of Engineering & Technology, Patiala. He has completed his Master Degree of Computer Applications from Thapar Institute of Engineering & Technology, Patiala. He is currently working as an Assistant Professor with the Department of Computer Science, Government Bikram College of Commerce, Patiala. He was selected as an outstanding reviewer from Knowledge-Based Systems (Elsevier). He has published more than 50 peer-review research papers (indexed in SCI-SCIE) and 5 international books. He is also serving as the guest editor of more than five special issues in various peer-reviewed journals. He is also in editorial board members of Current Chinese Computer Science (Bentham Science), Current Dissertations (Bentham Science), Journal of Fuzzy Logic and Modeling in Engineering (Bentham Science), Journal of the Institute of Electronics and Computer (IEC Science), Journal of PeerScientist, Artificial Intelligence Evolution, Acta Scientific Computer Sciences. His research interest includes Single-, Multi-, Many-objectives optimization (Bio-inspired, Evolutionary and Quantum), Soft computing (Type-1 and Type-2 fuzzy sets), Power systems, and Change detection using remotely sensed high-resolution satellite data. His research articles can be found in Knowledge-Based Systems (Elsevier), Advances in Engineering Software (Elsevier), Applied Intelligence (Springer), Journal of Computational Science (Elsevier), Engineering with Computers (Springer), Applied Soft Computing (Elsevier), Engineering Applications of Artificial Intelligence (Elsevier), Journal of Ambient Intelligence and Humanized Computing (Springer), among others. His research can also be seen in http://www.dhimangaurav.com

Dr. Ayush Dogra has worked as the Senior Research Fellow in the Department of Electronics and Communication Engineering, UIET, PANJAB UNIVERSITY. He has also worked as a Post-Doctoral fellow in the department of CBME, IIT Ropar and currently, he is working as CSIR-NPDF at CSIR- CSIO lab at Chandigarh. After his schooling from Kendriya Vidyalaya, Jakhu Hills, SHIMLA, he graduated in Bachelor of Engineering and Technology (ECE) from Guru Nanak Dev University, Amritsar. He received his Master’s degree from Punjabi University, Patiala. He has also attained a Master’s degree in Business Management (MBA) from IGNOU, Delhi. His doctoral research focuses on devising novel and innovative, market oriented mechanisms for medical image fusion. He has published numerous papers in highly cited journals and conferences.

Dr. Khalid Z. Elwakeel holds a PhD in Physical Environmental Chemistry and is an Associate Professor of Environmental Chemistry at Port-Said University, Egypt. He is an editorial board member and reviewer of some international journals and has reviewed more than 600 research articles for 91 international journals in the field of environmental research. He has also received multiple awards such as the award of the Kingdom of Saudi Arabia for the environmental management in the Islamic world October 2017 and the Egyptian Order of Distinction (first class) from the president of Egypt.

Dr. Brajesh Kumar is currently working as an Assistant Professor and Head in the Post Graduate Department of Chemistry, TATA College, Chaibasa, India. He received a Ph.D. in Chemistry from the University of Delhi, India in 2009. His research interests include the development of sustainable and eco- friendly techniques for nanoparticle synthesis and their applications for environmental remediation, active films of organic solar cells, nanomedicine, sensors, natural product extraction, purification and analysis, natural polymers, peptide chemistry, microwave and ultrasound assisted organic synthesis, and organic synthesis. Dr. Brajesh Kumar has credited different national and international fellowships and worked as a faculty member in various universities throughout India, Ecuador, and South Korea. He has also published numerous SCI/SCIE/Scopus research articles, ie- > 70  (h index = 22, Citations 1715) and is also an active reviewer of more than 60 journals.

Amit Kumar Mandal is a Chemical Biologist. Currently, he is an Assistant Professor and the Director of the Centre for Nanotechnology Sciences at the Raiganj University in India. He earned his M.Sc. and Ph.D. degree from the University of North Bengal. He started his career as an Assistant Professor at Vidyasagar University, India, in 2014. Thereafter, he joined to Raiganj University, India, in 2017, as a full-time Assistant Professor. He received the Young Scientist award-2017 and Green Technology Innovation award-2018. His research is focused on antimicrobial agents, biosensor, and host-pathogen interactions.

Dr. Mastinu completed his PhD in 2014 from University of Cagliari. The main topic of his research was the cannabinoids and energetic metabolism. Dr. Mastinu published more than 20 publications in indexed and international journals with h-index of 15. Now, Dr. Mastinu is the principal investigator for several projects: “Characterization new bioactive cannabimimetic natural entities in mouse models” and “Phytocannabinoids characterization from Cannabis sativa”. Dr. Mastinu was the winner of the Otsuka 2017 Prize for Neuropsychopharmacological Research.

Dr. Bijo Mathew is associate professor of Pharmaceutical Chemistry at the Ahalia School of Pharmacy, Palakkad, India. Dr. Bijo Mathew obtained his M.Pharm in Pharmaceutical Chemistry from The Tamilnadu Dr. M.G.R. Medical University, Tamilnadu, India in 2008 and Ph.D. in Pharmaceutical Sciences from Jawaharlal Nehru Technological University, Hyderabad, India in 2016. His main research interest is on the design of enzyme inhibitors, and especially monoamine oxidase and acetylcholinesterase inhibitors. Mathew's primary areas of focus are in drug discovery of neurodegenerative disorders, cancer and molecular modelling. He has published 123 papers, [h-index = 22; the number of citations: 1303 in Google scholar; h-index = 19; the number of citations: 1023 in Scopus [June 2020]. With 12 years of teaching and research experience, Mathew authored 1 book, 1 edited book, 5 book chapters and 22 invited talk in national and international level. Dr. B. Mathew serving as a chief executive guest editor of the journals of current drug targets and combinatorial chemistry and high throughput screening. He is an editorial member of the journal of Coronaviruses [Bentham Science]. He received one patent from Korean Intellectual Property of Office in the topic of protective or therapeutic compositions of neurological disorders containing furano chalcones as effective agents.

Seyed Mohammad Nabavi is a Biotechnologist and senior scientist in the Applied Biotechnology Research Centre, Baqiyatallah University of Medical Sciences, Tehran, Iran. His research interests are focused on natural products. Till now, he has authored/co-authored over 250 publications in international journals indexed in ISI and has more than 7000 citations to published articles and also more than 10 books.

Prof. Cord Naujokat earned a Ph.D. in Biochemistry at the Free University of Berlin, Germany as well as an M.D. at the University of Heidelberg. He earned bord certifications of Transfusion Medicine, Internal Medicine, Hematology/Oncology, and Laboratory Medicine at the University Hospitals Charite, Berlin, and Heidelberg, Germany. Since 2001 he worked as a senior scientist and since 2008 as Professor of Immunology at the Institute of Immunology, University of Heidelberg, Germany. His research is focused on molecular mechanisms driving cancer and metastasis, and on molecular and immune mechanisms employed by RNA viruses.

Dr. Dinesh Kumar Patel obtained PhD in Pharmaceutical Science from Indian Institute of Technology (BHU) Varanasi, India. He is presently serving as an Assistant Professor at Faculty of Health Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, India. His research interests are focused on importance of Natural products especially Plant secondary metabolite in Human health, Diabetes and its secondary complication, Flavonoids, Antioxidant and Phytopharmaceuticals. He is co-author of 80 papers published in international journals and many book chapters to his credit and has good citation index. He is reviewer for various international scientific journals and Travel grantee of various International Conferences.

Santanu Patra, PhD is working as a Group Leader at Institute of Advanced Materials, IAAM, Sweden & VBRI, India. He received his PhD in Chemistry from the Indian Institute of Technology (ISM) Dhanbad. His present research work focuses on novel lab-on-a-chip sensing technology along with the fabrication of separation devices. Dr. Patra has extensive experience in material science (materials design, synthesis, and characterization), nanocomposite synthesis, nanobiotechnology, catalysis science, and biosensor/sensor.

Professor Ishtiaq Qadri, PhD is a molecular virologist with interests in the pathogenesis of viral diseases, antiviral developments. He is investigating the underlying molecular mechanism(s) that govern the onset of viral-induced diseases and the particular focus is  on viral hepatitis (HBV & HCV), vector borne viral diseases (Dengue), and MERS-CoV.  He obtained his PhD from the Imperial College of Science and Technology, London, UK (1988) and later carried out postdoctoral fellowship work at the University California (UCSF) San Francisco (1988-1994) and University of Colorado Health Sciences Campus (UHSC), Denver  USA (1994-1999). He later served as faculty in the same institute. He has authored and coauthored over 200 research publications in peer reviewed journals. He established a  National Center of Virology and Immunology (NCVI) in Pakistan (2006-2011) and he is the Founder CEO of  IQ-institute  of infection and Infection (2012-). Currently, Dr Qadri is working as Professor in the  Dept of the Biological Sciences, Faculty of Science the King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at the treatment of liver cancer. He published more than 647 peer-reviewed research papers and registered 14 UK and International patents. On editorial boards of 41 journals. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career, Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include the development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. Currently, he is working on the development and commercialisation of human organs using graphene-based nanocomposite materials and stem cells technology. Recently he has commercialised a novel functionalised graphene oxide for drug/gene/vaccine delivery application. He also have been working in development of nanomaterials for medical and pharmaceutical and industrial application.

Prof. (Dr.) Gyan S. Shekhawat’s research involves various aspects related to Plant Biotechnology, Molecular Biology, Cellular Signaling and Stress Physiology. Prof. Shekhawat also working on biochemical aspects of medicinal and aromatic plant species and there in vitro propagation, conservation, specifically rare and endangered plants of Indian Thar Desert. Prof. Shekhawat completed his PhD from University of Rajasthan, and since then continuously engaged in research; initially started as a CSIR Post Doc Fellow, BOYSCAST fellowship and worked at University of South Florida, USA. Dr Shekhawat has also been awarded by INSA International Exchange Fellowship, Young Research Award, Professor YS Murthy Gold medal award by Indian Botanical Society. He has also completed several research projects funded by several national and international funding agencies. Prof. Shekhawat has published more than 75 research papers/articles in journal of international repute with cumulative Impact Factor 85 (Scopus) and H-index is 22 with cumulative citation 1600. Presently Prof (Dr.) Gyan S. Shekhawat presently working on Heme oxygenase-1 (HO-1), Nitric oxide (NO) signaling in plants and in vitro production of medicinally potent metabolites.

Dr Ali Ahmad received his PhD in VeterinaryMedicine (Parasite Immunology) from Cornell University, USA. He has recently retired from the post of associate professor at the Department of Microbiology,Infectious Diseases & Immunology, University of Montreal (Canada). He has worked for twenty-two years as a researcher in CHU (Centre Hospitalier Universitaire)Sainte Justine Research Center (affiliated with the University of Montreal). Currently,he is an associate researcher at this Research Center. He has extensive training and experience in investigating immune responses in viral infections,cancer and chronic inflammatory diseases. He has been the receiver of research grants from the Canadian Institutes of Health Research (CIHR), Canadian Cancer Society Research Institute (CCSRI), Crohn & Colitis Foundation of Canada (CCFC) and Canadian Glycomics Network. He has published one hundred peer-reviewed articles in well-reputed scientific journals including Journal of Immunology, Blood, Gastroenterology, Journal of Infectious Diseases, AIDS,Journal of Leukocyte Biology and Scientific Reports, etc. He has received several scholarships, salary and travel awards in his career.

Dr. Muhammad Akram is currently an Assistant Professor at the Department of Eastern Medicine, Directorate of Medical Sciences, Faculty of Science and Technology, Government College University Faisalabad. His research interests are Hyperuricemia, Xanthine oxidase inhibition by some selected medicinal plants, Enzyme Inhibition, Study of traditional system medicine (Indusyunic Medicine) Phytochemistry, and poisonous plants. He has contributed more than 96 publications in well-reputed journals.

Dr. Amjad Ali working as an Assistant Professor at Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology (NUST), since in 2013. He has been actively pursuing career in both academic and research. Dr. Amjad have been pursuing research in the area of Microbial Genomics, Proteomics and Systems Biology. Amjad’s group has produced interesting genomic and proteomic data and findings, thus far, he has contributed more than nearly 100 Journals (Citations: 1653 and H-index 22) along with several book chapters. These International journals include Nature Neuroscience, Scientific Reports, Frontiers in Microbiology, and Physiology, Integrative Biology, BMC Genomics and, Bioinformatics and J. Bacteriology, etc. Amjad has secured several research grants (as PI and Co-PI), on a highly competitive ground. He also has supervised several PhD and Master Thesis. During the past years, Amjad Ali has been awarded the “Best Research Paper Award” for the year 2013/14 by Higher Education Commission (HEC) Pakistan (2016). Awarded “Best Researcher Award” for the year 2016/17 by ASAB, NUST. Later, awarded with “Research Productivity Award (RPA)” in Biological Sciences (2017) by Pakistan Council for Science and Technology (PCST), 2018.

Dr. Leonard Amaral is an Emeritus Professor at the Institute of Hygiene and Tropical Medicine, Universidade Nova de Lisboa and a Distinguished Invited Scientist Fellow of the Fundacao de Ciencias e Tecnologia de Portugal. He received his PhD from the State University of New York (SUNY) in 1968. He has published over 400 scientific articles in peer-reviewed journals. His research interests include Infectious diseases, Tuberculosis, Multi-Drug Resistance, Molecular Biology, and Drug Development. His area of current main contributions include a) Development of therapy by which the resistance of MDR/XDR Mtb is by-passed and the non-killing macrophage is transformed into a killer of MDR/XDR Mtb, and b) Therapy of MDR/XDR TB with an inexpensive drug that is beyond patent protection, has no serious toxicity and has been now shown to cure XDR TB. Besides, he has received Medal of Merit from the Universidad Nova de Lisboa in 2018.

Dr. Muhammad Amin Ph.D., is Associate Professor of Department of Chemistry, University of Sargodha, Pakistan. His research area includes Nanochemistry, Computational Chemistry, Drug design and discovery. The goal is to design and discover pharmaceutical agents/Vaccines for contagious viruses by studying the theoretical aspects of virus entry to host cells and drug interaction at viral-host protein interfaces. In the context of ongoing pandemic COVID-19, I have an honor to publish my research related to repurposing of FDA approved for SARS-COV-2 related infections.

Cedric Annweiler, MD, PhD, is Full Professor in Geriatric Medicine and Biology of Aging and the Head of the Department of Geriatrics in the University Hospital of Angers, France. He is the Head of the Research Center on Autonomy and Longevity, Angers. Since 2017, he is also the Director of the Medical School of the Health Faculty in Angers University. With more than 275 peer-reviewed publications in high impact journals, Dr Annweiler pioneers a research work on the non-skeletal effects of lipophilic vitamins including vitamin D. The impact of this research has led to new therapeutic approaches in various diseases, including several patents.

Dr. Debasish Bandyopadhyay is currently working as an Assistant Professor (Tenure-track), Department of Chemistry, University of Texas Rio Grande Valley, USA. He received his PhD from the Department of Chemistry, Calcutta University, India. The title of the thesis was, “Studies on Nitrogen Heterocycles.” His specific areas of interest include Food Chemistry, Natural Product Chemistry, Organic/Medicinal Chemistry, and Green chemistry. He has published 75 scientific papers in peer-reviewed international journals along with 7 book chapters, 1 edited book and 1 patent. Besides, he is an editorial board member, associate editor, and a reviewer of 7, 1 and 46 international journals respectively. His research expertise include processing and chemical analysis of phytochemicals as they relate to human health and disease, elucidation of basic composition, structure and properties of the bioactive compounds and micronutrients, and extraction, isolation, characterization, and chemical modification of medicinally and/or industrially privileged chemicals from foods and food waste.

Dr. Branlant Christiane is a Director of Research from CNRS, exceptional class (DRCE2), Emeritus. She is currently working at the CNRS-Lorraine University IMoPA Laboratory Molecular Engineering and osteoarticular Physiopathology and is also in the Medical Faculty of the Lorraine University, Vandoeuvre Les Nancy, France. She received a PhD in Molecular Biology at the CNRS Institute of Molecular and Cellular Biology (IBMC) of Strasbourg under the direction of Pr J.P. Ebel in 1977. She has published 157 peer-reviewed articles in distinguished journals. Her research expertise includes RNA structure/function/evolution interaction with proteins, RNP assembly, structure and activity, Ribosome structure and biogenesis, Spliceosome structure, assembly, mechanisms of regulation, Small and large non-coding RNAs structure and function, Modified residues in RNAs, and Viral RNAs: structure, interactions with protein, translation, splicing.

Simone Brogi is an Assistant Professor at the Department of Pharmacy at University of Pisa (Italy). He leads the Computational Pharmacology and Toxicology Unit in the research group of Prof. Vincenzo Calderone. He graduated in 2005 in Biological Sciences from the University of Siena (Italy), where he also received his Ph.D. in Pharmaceutical Sciences in 2010. From 2011 to 2019 he directed the Molecular Modeling Unit at the Department of Biotechnology, Chemistry and Pharmacy (University of Siena) in the research group of Prof. Giuseppe Campiani. His research activity is focused on computational approaches in drug discovery.

Dr. Shiu-Wan Chan, Ph.D., is currently a lecturer in the Faculty of Life Sciences, affiliated with the Microbiology research group, at The University of Manchester, UK. After obtaining her Ph.D. in Molecular Biology at Edinburgh, she started her post-doctorate (also in Edinburgh) on pioneering hepatitis C virus (HCV) research and has made a major breakthrough in the discovery of a new genotype of the virus, its association with false negative blood donations and in the establishment of the current phylogenetic classification of the virus. Dr. Chan, as an author/co-author, has published more than 25 articles in various journals, having a noteworthy number of total citations, i.e. over 4,665.

Dr. Das completed his MSc from Tezpur Central University, India in Molecular Biology and Biotechnology followed by a PhD degree in Environmental Biotechnology from University of Quebec, Canada. Dr. Das has expertise in the fields of Nanobiotechnology and Environmental Biotechnology. He is currently working as an Associate Fellow at TERI-Deakin Nanobiotechnology Centre, India and also as an Honorary Fellow of IFM, Deakin University, Australia. His research team at TDNBC is working on the development of silk protein based nanoformulations for diverse applications. Dr. Das has about 65 peer-reviewed international research publications (25 as first author), 2 patents and series of conferences to his credit. He has significantly contributed as the core member of the scientific team in preparing the national guidelines for evaluation of nano-based agri-input and food products in India.

Marcus Vinícius Nora de Souza is a Senior Technologist at Oswaldo Cruz Public Health Foundation – RJ, and leads a research group in organic chemistry, with an emphasis in organic synthesis and medicinal chemistry, acting on neglected diseases (tuberculosis and malaria), cancer and synthetic methodologies. He has authored more than 250 manuscripts, 5 patents and 3 books, and their formation includes a PhD in organic and bioorganic chemistry (Universite de Paris XI (Paris-Sud) – France) with a stage at the University of Barcelona – Spain, and three postdocs in organic synthesis and medicinal chemistry (University of Florida – USA, Federal University of Juiz de Fora – MG, Pharmaceutical industry Genzyme - Boston – USA).

Bachelor on Sci, MSci and DrSci in Biochemistry (Federal of Rio de Janeiro University). Visiting researcher at the Department of Medical Parasitology, NYU, USA and European Molecular Biology Laboratory, Heidelberg, Germany. Was full Professor of Biochemistry at the Federal Fluminense University, Niterói, RJ, Brazil and Chief of the Biochemistry of Protein and Peptides Laboratory at Oswaldo Cruz Institute-FIOCRUZ, RJ, Brazil. Is Specialist in Sci & Technology Production and Innovation in Health of the Center for Technological Development in Healthy (FIOCRUZ-CDTS) and Researcher of the National Council of Scientific and Technological Development (CNPq) of Brazil.

After full degree in Medicine in 2007, I obtained in 2013 the Board in Internal Medicine at the Cagliari University, Italy. I’ve been working at the Department of Internal medicine, Allergy and Clinical Immunology. I focused my research interests on three main fields: autoimmunity, primary immunodeficiencies and rare diseases associated with dysregulation of immunity. In 2013 I have been elected as the Junior Representative in Biologicals Interest Group, at European Academy of Allergy and Clinical Immunology. Currently, I’m Associate Professor at University of Cagliari.

Dr Kapatral is a President, CEO of Igenbio, Inc Chicago. My background is in microbial-host genomics and bioinformatics to understand and discover new protein targets for drug discovery.

Professor Eduard Karamov is serving as the Head of Laboratory of Immunochemistry at the Gamaleya Center, Russia. Dr. Karamov graduated from the Lomonosov University of Moscow, Russia. He earned his PhD degree from the Ivanovsky Research Institute of Virology, Russia in 1974. His research is focused on HIV antivirals, microbicides, HIV vaccine, molecular epidemiology of HIV, HIV/TB coinfection, SARS-CoV-2 antivirals, virucidal agents and nanomaterials. Over the last three decades, Dr. Karamov has served as an expert of a number of international organizations.

Wattana Leowattana is currently a Professor of Tropical Medicine and faculty member of the Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University. He also serves as a Director of Hospital for Tropical Diseases during 2005 – 2009. Dr Leowattana earned his MD. from Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. He completed his residency in Clinical Pathology and Family Medicine at the Faculty of Medicine, Siriraj Hospital, Mahidol University in 1989 and a Master Degree in Clinical Science in 1991. He also earned a PhD Degree in Clinical Tropical Medicine in 2005.

I am an associate professor at Institute of Zoology, Chinese Academy of Sciences, Beijing, China. My research interests are epidemiology, machine learning, conservation planning, wildlife survey, animal movement, and species distribution modelling. I like to develop statistical tools to explore ecological patterns and processes, and to facilitate public health policies.

Prof. Yashpal Singh Malik is serving as a Principal Scientist & ICAR-National Fellow at the premier Veterinary Institute of the country- Indian Veterinary Research Institute (IVRI), Izatnagar India. Dr Malik has rich experience in veterinary and animal sciences with specialization in Microbiology and Biotechnology. His major research achievements include contributions in viral disease epidemiology, virus-host interactions, microbial biodiversity, characterization and diagnosis. Currently, he is working on development of new generation immunodiagnostics using synthetic and recombinant DNA technology. Prof Malik is recipient of several prestigious National, State and Academy level awards/honors. He has authored 5 books, 17 book chapters and 185 scientific research articles overall.

Prof. Stephen David Howard Malnick is the Head of the Dept. of Internal Medicine C Kaplan Medical Center. He is also a Clinical Associate Professor of Internal Medicine at the Hebrew University. He has contributed his valuable publications in different scientific journals. Besides, he is a member of the editorial board of the World Journal of Gastroenterology, World Journal of Hepatology, Journal of Hospital Administration, World Journal of Gastrointestinal Pathophysiology, and Turkish Journal Gastroenterology. Also, he is a reviewer of scientific journals including Annals of Pharmacotherapy, European Journal of Internal Medicine, Lancet Cardiology, World Journal Gastroenterology, Journal Hospital Infection, Digestive Disease Sciences, BMC Gastroenterology, World Journal of Hepatology, Annals of Internal Medicine, and EMBIO.

Dr. Ziad Moussa grew up in Calgary, Canada where he undertook undergraduate and postgraduate studies in chemistry at the University of Calgary (B.Sc. 1998, Ph.D. 2003). His Ph.D. research was conducted under the supervision of professor Thomas George Back and focused on the synthesis and evaluation of some novel selenium-based chiral auxiliaries and glutathione peroxidase mimetics. Following postdoctoral research at Texas A&M University (2003-2006) in the laboratories of Professor Daniel Romo, Dr. Ziad joined the Department of Chemistry at Taibah University as an assistant professor. Currently, he is an associate professor of organic chemistry at United Arab Emirates University (UAEU). His main research interests include the development of synthetic methodologies and the synthesis and characterization of novel selenium- and sulfur-based bioactive organic and heterocyclic compounds with anticancer, antiviral, and antimicrobial activities.

Giovanni Ribaudo received his degree at the University of Padova in 2011 (Medicinal Chemistry and Technology). In 2015, he graduated PhD at the University of Padova, after carrying out part of the research activity at the State University of New York, Albany (NY, USA). Between 2017 and 2019, he collaborated with a company operating in the fields of nutraceuticals and of natural compounds. His research interests comprehend synthetic, analytical and computational medicinal chemistry. In 2019, he joined the University of Brescia. His scientific production includes more than 40 peer-reviewed papers, 2 book chapters and 2 patent applications.

Dr. Asad A.A. Rizvi pursued an MS and PhD combined degree program at the Center for Biotechnology and Drug Design, Department of Chemistry, Georgia State University (GSU), Atlanta, GA, USA. Dr. Rizvi has published over 100 peer-reviewed articles in top ranking journals, two books and four book chapters. His research interests include pharmaceutical formulations (direct compressed tablets, topical and liquid), Ionic liquid formation and co-crystallization of the pharmaceutical compounds; nano and micro-encapsulation of the drugs for targeting and controlled release, multistep synthesis of small organic molecules, pharmaceutical analysis (forensics and method development), design and synthesis of novel monomeric and polymeric surfactants for separation of chiral and achiral compounds in micellar electrokinetic chromatography (MEKC).

Robert A. Schwartz, MD, MPH, DSc (Hon), FRCP Edin is in his third decade as Professor and Head of Dermatology at the Rutgers New Jersey Medical School; has served three terms on the Rutgers University Board of Trustees; and is the Chairman of the university-wide Academic Standards, Regulations and Admissions Committee. Professor Schwartz has previously been the Faculty President of the Rutgers New Jersey Medical School and a Visiting Professor at the Rutgers School of Public Affairs and Administration. Professor Schwartz is an Overseas Regional Adviser of the Royal College of Physicians of Edinburgh.

Consolato M. Sergi is full Professor of Pathology and Pediatrics, University of Alberta, Edmonton, Canada. Dr. Sergi was born in Rome (Italy), obtained his MD degree with honors, Pediatrics residency, and Fellowship in Pediatric Pathology at the University of Genoa, Italy, Pathology residency at the University of Heidelberg, Germany, the title of Clinical Reader at the University of Bristol, UK, PhD/Habilitation at the University of Innsbruck, Austria, MSc Public Health in Austria, and FRCPC (Pathology) from the Royal College in Ottawa. Dr. Sergi’s areas of interest are congenital heart disease, metabolic diseases, gastrointestinal/biliary diseases, carcinogenesis (bone/liver), and mitochondrial DNA‐ related cardiomyopathies.

Dr. SeyedAlinaghi attained his MD degree from Tehran University of Medical Sciences (1998-2006). He was awarded in Razi and Avicenna festivals. He is currently a PhD by Research in Epidemiology and has written 230 articles and 14 scientific, mainly focused on different aspects of HIV/AIDS. Currently, he serves as an assistant professor at the Tehran University of Medical Sciences. He has also served as a Member of Editorial Board in World Journal of Virology, Journal of Therapy and Management in HIV Infection, and Journal of HIV and STD Research.

Dr. Divakar Sharma PhD. is a Biotechnologist recognized in the field of Microbial Proteome research particularly for Tuberculosis and other microbial diseases especially in Drug resistance and Drug-induced studies. He is distinguished as one of the best researchers in the field of microbial proteomics with higher clinical relevance. Dr. Sharma has been published 50 plus research articles in journals of international repute, 14 plus book chapter and 1 book. He also serves as an editorial board member as well as a internal and external reviewer for several visible journals which have the higher impact in science.

Dr. Sudheesh K. Shukla's research area is focused on real-time analysis of biochemical markers for personalized healthcare diagnosis. In particular, he is interested in integrating functional biomaterials with micro- and nano- systems for sensing and actuation technologies His research interest align with the integration of biological molecules and other species with micro- and nanostructures of interest in the design and actuation technologies of novel (bio)sensors. Since 2010, he has carried out his research in Sweden, India, South Africa, Israel and China. Dr. Shukla is also engaged as an associate editor in several journals.

Dr. Alex Gutterres Taranto received his Doctorate Degree in Organic Chemistry from the Federal Fluminense University, UFF, Niteroi, Brazil. He was a Postdoctoral fellow at the University of Mississippi, Ole Miss, Oxford, the United States and International Center for Science and High Technology, ICS -UNIDO, Italy. Currently, he is an Adjunct Professor of Pharmaceutical Chemistry at the Federal University of São João del-Rei – UFSJ. He is also the Head of the Group of Molecular Modelling at Federal University of São João del-Rei. His research focus is on the development of new drugs using Computer Aided-Drug Design (CADD) methodologies. He has experience with Gaussian, Amber, Autodock Vina, Dock6, Mopac, Discovery Studio packages and Glide. This software can perform mechanical quantum calculations, docking, comparative homology modelling, molecular dynamics simulations, virtual screening and quantitative structure-activity relationship (QSAR). Also, Dr. Taranto has experience in Python and Shell Scripting Programming Languages. Besides, he has contributed his valuable publications in different scientific journals.

Dr. Enzo Tramontano graduated in Biology in 1990 at the University of Cagliari, Italy. He spent four years at the Department of Pharmacology of the Yale University School of Medicine, USA, as a Visiting Research Scientist and was then recruited at the University of Cagliari, Italy, where is currently a Full Professor of Microbiology and serves as a Dean of the Faculty of Biology and Pharmacy. His main fields of interest are HIV drug development, the interplay between viruses and the innate immune system, and the human endogenous retroviruses.

Dr Yasin Tuluce received his Doctorate in Biology from the Van Yuzuncu Yil University in 2005. Currently, he is a Professor of the Faculty of Medicine, Van Yuzuncu Yil University. He is a Member, an Editor, an Advisory Board Member and an Associate Editor of several international journals. Besides, he has won several awards such as Project ACUMEN, Van YYU Thanks Certificate. 2015, and Taylor & Francis Group "Certificate of Recognition" "Pharmaceutical Biology" Scientific Publication Certificate 2015. Moreover, he has published several papers in well-reputed journals.

Necla (Eren) TULEK is head of the Department of Microbiology at Medical School of Atılim University in Ankara. She is a specialist on Clinical Microbiology and Infectious Diseases and also has subspeciality on Immunology. She has more than hundred scientific article at WOS about Infectious diseases, microbiology and immunology.

Dr. Ram S. Upadhayaya is a serial entrepreneur and distinguished scientist specialized in the field of infectious diseases (HIV, Tuberculosis, and other neglected tropical diseases). He has more than 20 years of experience in industry and academia and holds 25 peer reviewed publications and 12 patents to his credit. In his previous assignments, Dr. Upadhayaya was associated with leading drug discovery companies like Lupin, Ranbaxy and Bioimics, Sweden. He briefly worked as Forskare (Asst. Professor) at Uppsala University, Sweden. During this journey he contributed to the discovery and development of three clinical candidates for different disease indications. Currently, he is the CEO of Laxai Life Sciences, Hyderabad and Co-founder & CSO of Ohm Oncology Inc., USA, a company focusing on oncology and neoplasms with a vision to bring forth novel drugs for management of treatment-refractory and difficult to treat cancers.

Dr. David Jay Weber is a Professor of Medicine, Pediatrics and Epidemiology, Associate Chief Medical Officer of UNC Health Care, and a Director of regulatory services for the North Carolina Translational and Clinical Sciences Institute. He serves as a Medical Director of Hospital Epidemiology (infection control) and as a Director of the UNC Health Care Anti - Infective Stewardship (a broad-based program that includes dedicated ID pharmacists, drug information specialists, pediatric and adult infectious disease specialists, and molecular microbiologists). He is also board-certified in internal medicine, infectious disease, critical care medicine and preventative medicine. His research career has focused on healthcare-associated infections, antibiotic stewardship, new and emerging diseases (Pfiesteria, Cryptosporidia, norovirus) and vaccine implementation. Dr Weber also chairs the North Carolina Department of Health.

Dr. Yakisich received his MD degree from the University of Buenos Aires, Argentina and his PhD from The Karolinska Institute in Stockholm, Sweden. He completed postdoctoral training in Texas A&M University. He is currently Assistant Professor in the Department of Pharmaceutical Sciences, Hampton University in Virginia. His research interest includes preclinical research in cancer biology with special focus on plasticity, stemness and chemoresistance of cancer cells with the aim to develop new combinational based therapy. He has published more than 50 peer reviewed original research and review articles, 4 book chapters and served as guest editor in leading journals.

Dr. Leiliang Zhang is presently serving as a Professor and Principal Investigator at the Institute of Basic Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, China. He completed his B.S. in Biochemistry and Molecular Biology, College of Life Sciences, Peking University, Beijing, China in 1999. He further obtained a PhD from College of Life Sciences, Peking University, Beijing, China in 2004. He has contributed his valuable publications in different scientific journals.

Dr Muhammad Ammar Athar graduated from Dr Qingge Li’s State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics at Xiamen University, China. His research work was focused on the molecular diagnosis of infectious diseases. He developed novel real-time PCR/MMCA based assays for the detection of drug-resistant mutations in Hepatitis B virus and genotyping/quantification of the Hepatitis C virus. He was awarded the "Best International Researcher Award 2013" at Xiamen University. During his postdoctoral fellowship in the Laboratory of Cancer Biomarkers and Liquid Biopsy of Henan University China, he conducted his research on the discovery of non-invasive biomarkers for monitoring disease status and development of assays for detection of common mtDNA, based on droplet digital PCR technology. He has published his work in peer-reviewed journals. His current research interests are the development and validation of diagnostic tools to monitor emerging viral infections, especially in the Pakistani population.

Dr. Kirtikumar C. Badgujar is working as an Assistant Professor in, SIES College of Arts, Science and Commerce, Sion, Mumbai, India. He has completed his M.Sc. degree from North Maharashtra University, Jalgaon in 2008; where he secured University Rank FIRST and GOLD-MEDAL. He has completed his Ph.D. Research Studies from the Institute of Chemical Technology (ICT: Formerly UDCT), Mumbai, India in December 2015, under the guidance of Prof. B. M. Bhanage. He secured several Prestigious Awards during his Ph.D. research studies such as Young Scientist Award and Best Ph.D. Research Thesis Award etc. Till time in his research studies, he has published Twenty Eight Peer Reviewed Research Articles (in International Reputed Journals) including High Impact Reviews and Reference Book-Chapter. He has Five Granted and Two Filed Indian patents in his credit. His research interest includes Enzymology, Biochemistry, Green chemistry, Enzyme- stability, Biocatalysis, Drug chemistry, Medicinal chemistry, Biomaterials and Biomass valorisation etc.

Dr. Asis Bala, received PhD from Jadavpur University, Kolkata India and Completed Post-Doc. at Department of Pharmacology, Faculty of Health Sciences, University of the Free State, South Africa. His area of interest are, Pathophysiology of Communicable and non-communicable Disease; Pharmacology; Toxicology; Free Radical Biology and cellular Inflammation and Immunopharmacology of different diseases. He supervised number of Masters and PhD students and acquired more than 500 Scopus citation in 2020 (April) having Scopus h index 14.

Dr. Abdelmjid BOUAZIZI got his Degree in Chemical Physical sciences (2011) from the Faculty of Sciences and Technologies (FST), Cadi Ayyad University of Marrakech (Morocco) and Magister. (2013) and Ph.D. (2018) in Materials Science and Environment from FST of Mohammedia, Hassan II University of Casablanca (Morocco). He awarded the award of Hassan II University of Casablanca for the Best Thesis 2018. He is interested in research in ceramic membrane and membrane technologies. He has wide experiences in both Research and Academia concerning «Nanomaterials Characterization “. Additionally, he has contributed to the preparation and characterization of low-cost microfiltration, ultrafiltration and nanofiltration membranes based on clay, pozzolan and phosphate for dyes and metal cations rejection. He has published more than 14 articles in highly recognized scientific journals published by Elsevier (Citations 275, h-index 10) and presented many papers in reputed national and international conferences. He is a member in many scientific projects. Reviewer of many international journals, as well as a member of a number of international associations, to name a few: Moroccan Membrane and Desalination Society.

Dr. Tai-Heng Chen currently works at the Department of Pediatrics and Neurology, Kaohsiung Medical University Hospital. He has been researching Pediatrics, Neurology, Neuromuscular Disorders, Genetic Diagnosis, and Emergency Medicine. His interests of research are pediatrics, neurological infectious disease, neurocritical care, neuromuscular disorders, non-coding RNA and Therapeutic Potentials in Spinal Muscular Atrophy and Human Induced Pluripotent Stem Cells.

Dr. Mohammad Faheem Khan, Assistant Professor, Era University of Lucknow India, has more than 12 years of experience in natural product chemistry and medicinal chemistry. His research areas include: Identification of bioactive compounds from plants, development of new methodologies to purify the bioactive compounds as well as computer aided drug designing. He received his PhD in chemistry from Centarl Drug Research Institute, Lucknow India under the mentorship of Dr. Rakesh Maurya, a renowned scientist of India. Dr. Khan has published more than 40 research articles, reviews and book chapters in reputed journals. He is a life member of the Association of Chemistry Teachers of India and Society of Ethnopharmacology, India.

Dr. Anoop Kumar is currently working as an Assistant Professor at the Department of Pharmacology and Clinical Research, Delhi Pharmaceutical Sciences & Research University, India. Previously, he has worked as an Assistant Professor at the Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli. He has also worked in the Medical Affairs and Clinical Research Department of Sun Pharmaceutical Limited, Gurugram and Translational Health Science Institute (THSTI), Faridabad, India. Dr. Kumar has authored more than 60 research and review articles and 15 book chapters in International Journal of repute. He has also filed 2 provisional patents and 1 copyright. He is also an author of 2 books.

Dr. Mallika Lavania received her PhD in Life Sciences (Biotechnology) from the National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Agra, India in 2009. She has supervised 10 National and International projects. Currently, she is working as a scientist in the Enteric Virus Group at the National Institute of Virology, India. She has published 55 articles in well-reputed national and international scientific journals and 3 book chapters. She has also received scholarships and awards in her career such as ICMR-Senior Research Fellowship, Best poster Award Nov, Young Scientist Award, Best Oral Presentation Award Oct etc.

Dr. Nguyen Quoc Khanh Le is an Assistant Professor with the Professional Master Program in Artificial Intelligence in Medicine, Taipei Medical University, Taiwan. He earned his MS and PhD degree in the Department of Computer Science and Engineering, Graduate Program in Biomedical Informatics, Yuan Ze University, Taiwan. After obtaining his PhD degree, he worked as a Research Fellow at the School of Humanities, Nanyang Technological University, Singapore. His research interests are artificial intelligence, deep learning, bioinformatics, computational biology, radiogenomics, and healthcare informatics.

Professor Vagner Ricardo Lunge holds a Master's in Microbiology (1993) and a PhD in Genetics and Molecular Biology (2000) from the Federal University of Rio Grande do Sul (UFRGS) in Brazil. He also has specialization in Food Microbiology (1995) at Cornell University in USA. He currently teaches undergrad courses of Biomedicine, Agronomy, Veterinary Medicine and a grad course of Cellular and Molecular Biology applied to Health (MSc and PhD) at Lutheran University of Brazil (ULBRA). He has experience in Genetics, Biochemistry, Biotechnology, Virology and Molecular Biology, working on Molecular Diagnosis in the Human / Animal Health and Agroindustry fields.

Dr. Mukesh Meena is currently working as an Assistant Professor at the Laboratory of Phytopathology and Microbial Biotechnology of the Department of Botany at Mohanlal Sukhadia University, Udaipur (Rajasthan), India. Dr. Meena has more than 9 years of research and 5 years of teaching experience. Dr. Meena did his M.Sc. (Botany) and Ph.D. (Botany) degrees from the Department of Botany, Banaras Hindu University, Varanasi, India. His areas of research and work expertise are in; plant-microbial interactions, fungal biology, toxic metabolites, plant-pathogen interaction, fungal biomolecules, plant-growth-promoting rhizobacteria (PGPR), biocontrol etc. Dr. Meena has more than 70 publications in peer-reviewed journals of national and international repute. He is an active member of various scientific societies such as the Mycological Society of India (MSI), The Indian Science Congress Association (ISCA) etc. He has been awarded the best paper presentation award in the Fourth International Conference on Advances in Applied Science and Environmental Technology – ASET, Bangkok, Thailand in 2016.

Dr. Zeeshan is working as an Assistant Professor at Umm Al Qura University. His research in M. Phil and Ph.D. broadly fell in the area of Organic, Pharmaceutical and Analytical Chemistry. Particularly, he is specialized in developing new methods and protocols for in vitro analysis of drug-drug interactions. He used HPLC coupled with UV-Vis spectrophotometry as analysis tools. He also researched for six months as a Visiting Scholar at the Department of Agricultural and Biological Engineering, Purdue University, Indiana. At Purdue, his stay was recognized by the Pakistani government and awarded the Higher Education Commission (HEC).

Dr. Sukhes Mukherjee is working as Associate Professor in Biochemistry Department of AIIMS Bhopal. He is a committed and hard-working faculty member involved in teaching and in research for the last 16 years. He has a very active academic and research career. He has published more than 42 papers in peer-reviewed journals. He has also presented his work at several national and international conferences. He got the best paper award from the “Association of Clinical Biochemists of India” in 2008. He got the International travel fellowship to attend the Neurochemistry conference at Busan, South Korea in August 2009 and another AACC fellowship in 2011. He is regularly giving training on behalf of his department to undergraduate and postgraduate medical students and himself getting training in the cutting-edge technologies of advancement in the field of Advanced Biology, Biochemistry and Molecular biology.

Dr. Kamal Niaz received his PhD in the field of Toxicology and Pharmacology at the Tehran University of Medical Sciences (TUMS), Iran in 2017. He was an Early Stage Researcher (ESR) in 2017-18 at the University of Teramo-Italy. Dr. Niaz has expertise in the domain of environmental toxicants, diabetes, endocrine disruptor and genomic disruption. Currently, Dr. Niaz has published almost 50 plus articles in prestigious national and international journals within a short period with 110+ impact factors along with 40 Book Chapters with various publishers such as Elsevier, Springer, and Bentham Science. Dr. Niaz has been working as Assistant Professor at the Department of Pharmacology & Toxicology, Faculty of Bio-Sciences, Cholistan University of Veterinary & Animal Sciences (CUVAS), Bahawalpur, since 2018.

Dr. rer. nat Arli Aditya Parikesit is the head of bioinformatics department at i3L. He finished his bachelor and master both in Chemistry, University of Indonesia. In order to pursue the degree in Bioinformatics, he accepted DAAD (German Academic Exchange Service) fellow to conduct doctorate research at Bioinformatics Group, Faculty of Informatics and Mathematics, University of Leipzig, Germany. His doctoral research is focused on the utilization of modern protein domain annotation techniques to the three domains of life. In addition, Dr. Arli is also an expert on immunoinformatics, in silico drug design, and in silico transcriptomics.

Dr. Vaishali M. Patil obtained her PhD degree (2014) in Pharmaceutical Sciences from Birla Institute of Technology, Mesra, India. Since 2017, Dr. Vaishali is Associate Professor in the KIET Group of Institutions (Department: School of Pharmacy) at Dr. A. P. J. Abdul Kalam Technical University, India. She has experience in application of computer aided drug design, QSAR and related medicinal chemistry approaches for biologically important classes of organic compounds. In addition she has experience in handling computational software and interpretation of analytical data (IR, NMR, MS). Dr. Vaishali is author of more than 45 papers published in indexed/peer reviewed Journals and 13 book chapters (Elsevier, Springer, Nova, etc.) with citation index of 200. She has received funding from various agencies to promote research activities of her lab.

Dr. Indra Neel Pulidindi is currently working on “Carbon fiber reinforced composites (CFRPs)” as a postdoctoral researcher in the laboratory of Prof. Xinling Wang at Shanghai Jiao Tong University, China. Dr. Pulidindi worked as a visiting scientist in the laboratory of Prof. Tae Hyun Kim at Hanyang University, Republic of Korea during 2016-2017 where he gained expertise on biomass characterization and utilization for biochemicals production. He has worked as postdoctoral researcher in the laboratory of Prof. Aharon Gedanken at Bar-Ilan University, Israel from 2010 to 2016, during which he gained experience on the conversion of biomass to biofuels and biochemicals and developed nanomaterial based sensors for biomolecules. He obtained Ph.D., degree from IIT Madras, India, in 2010 where he produced the doctoral thesis entitled “Development and exploitation of carbon materials from plant sources” under the supervision of Professor T. K. Varadarajan and Prof. B. Viswanathan. He has published 38 peer- reviewed manuscripts, 1 patent, applied for 4 patents, authored 1 book, 5 book chapters and 1 e-book.

Arslan Sehgal is working as an Assistant Professor, Department of Bioinformatics, University of Okara, Okara, Pakistan and Visiting Assistant Professor, Department of Bioinformatics and Biotechnology, Government College University Faisalabad (GCUF), Faisalabad, Pakistan. He defended his PhD in Cell Biology successfully from Chinese Academy of Sciences, Beijing with the specialization of bioinformatics and computational drug designing. Moreover, he has authored/co-authored thirty (30) international research/review articles in peer reviewed journals and one (01) complete book as principle and corresponding author. For his contributions in the field, he was awarded with Research Productivity Award for the year of 2015, 2016 and 2017 by CUI, and CAS-TWAS president fellowship award 2015. Moreover, in 2018, he was honored with the Excellent International Student of UCAS 2018.

Dr. Chandrabose Selvaraj is currently working as a Senior Researcher in the Department of Bioinformatics, Alagappa University, India. He completed his doctoral studies from Bioinformatics (2014) from Alagappa University, India. He worked as a post-doctoral researcher in multiple international esteemed institutes that include National Center for Toxicology Research, Food and Drug Administration (USA); Central European Institute of Technology (Czech Republic), Konkuk University (Republic of Korea) and Indian Institute of Technology- Mandi (India). He has been awarded as with European OP VVV MSCA-IF call 2017, ORISE IF- 2015, BIRD Special Mention award - 2012, and Young Researcher award-2010. His expertise includes Computer simulation of biomolecules, and recognition mechanism for protein-protein, protein-nucleic acid, protein- carbohydrate, and protein-ligand interactions.

Dr. Rahul Pratap Singh earned his B. Pharm. and M. Pharm. degrees from Bundelkhand University, Jhansi, India. He completed his Ph.D. in Pharmaceutics (cancer nanomedicines) in 2017, under the supervision of Dr. M.S. Muthu and Prof. B.L. Pandey from Banaras Hindu University, Varanasi. Dr. Singh is an Assistant Professor at the Department of Pharmacy, School of Medical and Allied Sciences, GD Goenka University, Sohna, Gurgaon, India. He has authored dozens of scientific publications and currently editing one book on lung cancer nanomedicines. He received several fellowships; awards including research grant from Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Government of India, Dr. Singh is working as a research project reviewer of the Department of Science and Technology, New Delhi since 2017 onwards, He is an Editor-Board Member of several other scientific journals, including Current Protein & Peptide Science, Acta Scientific Pharmaceutical Sciences and International Research Journal of Pharmacology.

Dr. Avadhesh Kumar Yadav is Assistant Professor in Department of Physics, F. A. A. Government Postgraduate College Mahmudabad Sitapur, Uttar Pradesh, India. He has done his Ph.D. from University of Lucknow, Lucknow, India and post doctoral research from Indian Institute of Technology (BHU) Varanasi India. His research includes glass, glass ceramics, Science Communication, humidity and gas sensors. Currently, I am working on Coronavirus and COVID-19 and its impact on mental, psychological and physical health in peoples. He has published more than 3o research articles in journals of international repute. He has also published a book on Science Communication: Issues and Challenges.

Dr Zhou got his PHD degree from Shanghai Institute of Organic Chemistry as the major of rational drug design. He finished his Postdoc training in Mcgill university as major of rational drug design. Dr Zhou come to IMB/CAS as associate professor since 2010, and became full professor of IMB/CAS in 2017. Since 2018, he became a professor in Zhejiang normal university and the director of DDIC. His group focuses on the development of anti-viral drugs and anti-cancer drugs. He has been approved for four NCSF grants and was nominated as “Xiehe’ star”. Up to now, his group has published more than 50 papers and 10 patents.

Jorddy Neves Cruz is a Professor and Researcher in Federal University of Pará and Researcher in Paraense Emílio Goeldi Museum. He obtained his degree of B.Sc in Pharmaceutical Sciences from Federal University of Pará, Brazil in 2010, M.Sc in 2013 and then completed his PhD in Medicinal Chemistry in 2019. His research focuses on (1) Medicinal Chemistry, with a special emphasis in drug design; (2) molecular modeling approaches in the discovery of new drugs and (3) evaluation of biological activities and pharmacological potential of natural and synthetic compounds.

Dr. Pooja Mittal holds a PhD in Pharmaceutical Engineering & technology from BHU Varanasi University and Pharmaceutics at Maharishi Markendeshwar University, Sadopur Ambala from April 2019. She has been awarded as Women Forum Young Scientist award by Society of Pharmaceutical Education and Research 2017 (SPER) annual international conference held at Jaipur, Rajasthan during 3-4 march, 2017. Her areas of interest are Nanotechnology, Conjugation of Polymers, Treatment of Cancer by Nanotechnology-based approaches, Active and Passive targeting. QBD based approaches for the Optimization, Research & Development, Pharmacovigilance & Intellectual Property Rights. She is also a member of different societies.

Dr. Mukesh Singh Sikarwar is an Associate Professor at AIMST University, Malaysia. He earned his Ph.D. degree from the KLE University, Belgaum, India. He started his career as an Assistant Professor at K.L.E. University College of Pharmacy, Belgaum, India in 2011. Thereafter, he joined AIMST University, Malaysia, in 2013, as a full-time Assistant Professor. His research is focused on Pharmacognosy, Phytochemistry, Pharmaceutical Organic Chemistry I, II & Alternative medicine, Pharmaceutical analysis. He is also an Editorial Board Member of different journals.